BioSpace News Archive

Zylox-Tonbridge, a leading medical device company in the peripheral and neurovascular interventional market in China, announced a new strategic partnership with Avinger, a commercial-stage medical device company developing and marketing the first and only intra-vascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease.

AlzeCure Pharma announced that the company’s presentation at the Alzheimer’s conference AD/PD 2024, regarding new preclinical data with its leading clinical drug candidate NeuroRestore ACD856, which is being developed with a focus on Alzheimer’s disease, is now available on the company’s website.

Senzime Senzime, an industry leader in precision-based patient monitoring solutions, announces its largest hospital win to date.

MitoRx Therapeutics announces the appointment of four distinguished international experts to its Scientific Advisory Board : Caroline Le Guiner PhD, Milos Filipovic PhD, Professor Phil Hansbro PhD, and Professor Annemieke Aartsma-Rus.

AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the appointment of Janine Schuurman, PhD, as a scientific advisor.

CERo Therapeutics Holdings, Inc., today announced the publication in Clinical Cancer Research , a journal of the American Association for Cancer Research, a paper titled “ Therapeutic Targeting of TIM-4-L With Engineered T Cells for Acute Myeloid Leukemia.”

3T Biosciences today announced that it has entered into multiple additional collaborations with leading academic centers and principal investigators to further fuel 3T’s best-in-class 3T-TRACE (T-Cell Receptor Antigen and Cross-Reactivity Engine) pHLA target discovery platform.

Womed, the women’s health company pioneering innovative, safe and effective treatments to free women from uterine pathologies, announced that the results of the PREG2 clinical trial demonstrated Womed Leaf® is effective in the management of severe and moderate intrauterine adhesions, the primary mechanical cause for female infertility.

Reviva Pharmaceuticals Holdings, Inc. today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the 36th Annual ROTH Conference, taking place March 17-19, 2024.

Clene Inc. today announced that it will participate in the 36th Annual ROTH Conference being held March 18-19, 2024.